Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GK1-399 in Type 2 Diabetes Mellitus
NCT01474083Phase 2Completed
- Sponsor
- vTv Therapeutics
- Start
- Nov 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cadisegliatin in type 2 diabetes mellitus (T2DM), sponsored by vTv Therapeutics. Started Nov 2011; status: completed.
02
Drugs
cadisegliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01474083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01474083.